Fingerprint
Dive into the research topics of 'Predicting hematologic toxicity in patients undergoing radioimmunotherapy with 90Y-ibritumomab tiuxetan or 131I-tositumomab'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Predicting hematologic toxicity in patients undergoing radioimmunotherapy with 90Y-ibritumomab tiuxetan or 131I-tositumomab
Sébastien Baechler, Robert F. Hobbs, Heather A. Jacene, François O. Bochud, Richard L. Wahl, George Sgouros
Research output: Contribution to journal › Article › peer-review
24
Scopus
citations